The NCI Fiscal Year 2026 (FY26) Annual Plan & Professional Judgment Budget Proposal: Leading Progress Against Cancer has been released. It presents NCI’s assessment of the optimal funding needed — $11.5 billion in FY26 — to fully capitalize on the extraordinary scientific opportunities before us and advance our shared goal of ending cancer as we know it.
The FY26 annual plan and budget proposal builds on the momentum created by the Cancer Moonshot and reflects our vision for future progress. It covers the entire NCI portfolio and highlights four important areas of opportunity for FY26, illustrating how sustained investments in each area would support the goals of the National Cancer Plan. These include addressing the rise in cancer among young adults, understanding the comprehensive effects of cancer on the body, identifying ways to alleviate the financial burdens associated with cancer care, and developing vaccines that can prevent or treat cancers.